Annual report [Section 13 and 15(d), not S-K Item 405]

Commitments and Contingencies - Additional Information (Details)

v3.26.1
Commitments and Contingencies - Additional Information (Details)
$ in Thousands
12 Months Ended
Jul. 12, 2017
USD ($)
Number
Jun. 12, 2017
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Loss Contingencies [Line Items]        
General and administrative expenses     $ 8,179 $ 10,687
Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] | API Supply Agreement [Member]        
Loss Contingencies [Line Items]        
Proceeds from supply agreement   $ 31,800    
Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] | API Supply Agreement [Member] | PGLG [Member]        
Loss Contingencies [Line Items]        
Percentage of right to supply   25.00%    
Agreement term   15 years    
Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] | Revised API Agreement [Member]        
Loss Contingencies [Line Items]        
Agreement term 5 years      
Number of renewals | Number 10      
Cumulative purchase amount $ 47,000      
Annual purchase target amount 5,000      
Target profit $ 2,500